Colgate-Palmolive is expected to report Q1 2026 consensus revenue of $5.21 billion and EPS of $0.95, with its current share price of $82.36 trading significantly below the average analyst target of $96.55.
The primary focus for investors remains organic sales growth, specifically the performance of the Hill’s Pet Nutrition segment following the strategic exit from private-label contracts.
Analysts are looking for continued strength in emerging markets to balance cautious consumer spending in North America and potential impacts from global tariffs. Management’s progress in expanding gross margins through productivity initiatives and the integration of the Prime100 acquisition will also be key determinants of the post-earnings reaction.